Vaccins

A la une adulte

Hepatitis B challenge dose in vaccinated healthcare personnel susceptible at hire

  Publié le 05-06-2026 |  Article original (Full-text)  |  Vande Hey, Jenna M. et al.  |   Vaccine 2026; 82(In progress): 128589

Due to the nature of their work, healthcare personnel are at an increased risk for hepatitis B infection, and some may not respond fully to the vaccine. Many health systems evaluate hepatitis B vaccine response of new employees with history of vaccines series completion at time of hire. Individuals found...

Lire la suite

A la une pédiatrique

Safety of supervised hospital vaccination in children at risk of hypersensitivity: A 9-year study

  Publié le 05-06-2026 |  Article original (Full-text)  |  Donesana, Myriam et al.  |   Vaccine 2026; 84(In progress): 128663

Fear of allergic reactions is a frequent cause of vaccine hesitancy among families of children with allergic diseases. Vaccination in a supervised hospital setting is often recommended for children considered at increased risk of hypersensitivity. However, real-world data on the safety and impact of...

Lire la suite

Point de l'expert

Infections respiratoires à VRS du nourrisson : que retenir de la comparaison Beyfortus® / Abrysvo® en vie réelle ? (EPI-PHARE)

  Publié le 05-06-2026 |  Point de l'expert  |  L'équipe éditoriale GNM
L'équipe éditoriale VaccineXPERT Officine

Le virus respiratoire syncytial (VRS) reste l’une des principales causes d’infections respiratoires basses et d’hospitalisations chez le nourrisson, en particulier lors de la première saison hivernale. Deux stratégies de prévention sont aujourd’hui disponibles...

Lire la suite